Search Results - "Prasanna Kumar, K.M"

Pancreatic exocrine insufficiency in type 1 and type 2 diabetics of Indian origin by Shivaprasad, C, Pulikkal, Annie A, Prasanna Kumar, K.M

“…Abstract Background Pancreatic exocrine insufficiency has been frequently described in both type 1 and type 2 diabetes. Fecal elastase test has been…”
Get full text

Effectiveness of vildagliptin versus other oral antidiabetes drugs as add-on to sulphonylurea monotherapy: Post hoc analysis from the EDGE study by Prasanna Kumar, K.M, Phadke, U, Brath, H, Gawai, A, Paldánius, P.M, Mathieu, C

“…Highlights • Retrospective data of 3756 patients with T2DM on SU monotherapy. • Vildagliptin resulted in better glycaemic control without tolerability issues…”
Get full text

Lixisenatide Reduces BeAM Value (Difference Between Bedtime (Be) and Next-Day Pre-Breakfast (AM) Glucose): A Clinical Indicator for Initiation of Prandial Therapy by Woo, Vincent, Shaefer, C, Brath, H, Digenio, A, Lin, Jay, Prasanna Kumar, K.M, Zisman, A

Get full text

A Study of Association of Ankle Brachial Index (ABI) and the Highly Sensitive C - Reactive Protein (hsCRP) in Type 2 Diabetic Patients and in Normal Subjects by K O, Thejaswini, M S, Roopakala, G, Dayananda, S P, Chandrakala, Kumar K M, Prasanna

“…The Ankle-Brachial Index (ABI) objectively assesses the lower extremity arterial perfusion. A low ABI suggests atherosclerosis and Peripheral Arterial Disease…”
Get full text

Immunogenicity of human and bovine insulin in type 1 diabetes mellitus patients by Himanshu, M, Bhat, Chetan B, Ramchandran, Sarita, Bhat, K Geetha, Kumar, Prasanna K M

“…The advantages of synthetic insulin (human insulin) over bovine insulin in the treatment of type 1 diabetes mellitus (DM) are much debated in terms of potency…”
Get more information

Efficacy and safety of saxagliptin in older participants in the SAVOR-TIMI 53 trial by Leiter, Lawrence A, Teoh, Hwee, Braunwald, Eugene, Mosenzon, Ofri, Cahn, Avivit, Kumar, K M Prasanna, Smahelova, Alena, Hirshberg, Boaz, Stahre, Christina, Frederich, Robert, Bonnici, Francois, Scirica, Benjamin M, Bhatt, Deepak L, Raz, Itamar

“…To examine the safety and cardiovascular (CV) effects of saxagliptin in the predefined elderly (≥65 years) and very elderly (≥75 years) subpopulations of the…”
Get full text

1372-P: Micro and Macro Complications Three-Year Follow-up in LANDMARC—Longitudinal Nationwide Study on Real-World Outcomes of Type 2 Diabetes in India by RAIS, NADEEM, DAS, ASHOK K., JOSHI, SHASHANK R., MITHAL, AMBRISH, KALRA, SANJAY, GOPALAKRISHNAN UNNIKRISHNAN, AMBIKA, THACKER, HEMANT, SETHI, BIPIN, CHOWDHURY, SUBHANKAR, SUGUMARAN, AMARNATH, SATPATHY, ASHWINI, GADEKAR, ARVIND, MENON, SHALINI K., NEOGI, RENUKA, CHODANKAR, DEEPA, TRIVEDI, CHIRAG, KUMAR WANGNOO, SUBHASH, ZARGAR, ABDUL H., PRASANNA KUMAR, K.M.

“…Microvascular and macrovascular complications were evaluated during the 3 years (yrs) of LANDMARC, a prospective observational study (CTRI/2017/05/008452) that…”
Get full text

1435-P: Therapeutic Patterns at Three-Year Follow-up in LANDMARC—Longitudinal Nationwide Study on Real-World Outcomes of Type 2 Diabetes in India by THACKER, HEMANT, DAS, ASHOK K., JOSHI, SHASHANK R., MITHAL, AMBRISH, KALRA, SANJAY, GOPALAKRISHNAN UNNIKRISHNAN, AMBIKA, PRASANNA KUMAR, K.M., SETHI, BIPIN, CHOWDHURY, SUBHANKAR, SUGUMARAN, AMARNATH, SATPATHY, ASHWINI, GADEKAR, ARVIND, MENON, SHALINI K., NEOGI, RENUKA, CHODANKAR, DEEPA, TRIVEDI, CHIRAG, KUMAR WANGNOO, SUBHASH, ZARGAR, ABDUL H., RAIS, NADEEM

“…Therapy patterns across various subgroups were examined at the end of third year (yr) in LANDMARC, a prospective observational study (CTRI/2017/05/008452),…”
Get full text

1427-P: Glycemic Trend in Metropolitan vs. Nonmetropolitan Cities of India—Three-Year Follow-up Results of LANDMARC by GOPALAKRISHNAN UNNIKRISHNAN, AMBIKA, DAS, ASHOK K., JOSHI, SHASHANK R., MITHAL, AMBRISH, KALRA, SANJAY, PRASANNA KUMAR, K.M., THACKER, HEMANT, SETHI, BIPIN, CHOWDHURY, SUBHANKAR, SUGUMARAN, AMARNATH, SATPATHY, ASHWINI, GADEKAR, ARVIND, MENON, SHALINI K., NEOGI, RENUKA, CHODANKAR, DEEPA, TRIVEDI, CHIRAG, KUMAR WANGNOO, SUBHASH, ZARGAR, ABDUL H., RAIS, NADEEM

“…Glycemic trends in type 2 diabetes (T2D) participants from Indian metropolitan and non-metropolitan cities have been less studied and hence, were evaluated in…”
Get full text

1423-P: Glycemic Status at Three-Year Follow-up in LANDMARC—Longitudinal Nationwide Study on Real-World Outcomes of Type 2 Diabetes in India by JOSHI, SHASHANK R., DAS, ASHOK K., PRASANNA KUMAR, K.M., MITHAL, AMBRISH, KALRA, SANJAY, GOPALAKRISHNAN UNNIKRISHNAN, AMBIKA, THACKER, HEMANT, SETHI, BIPIN, CHOWDHURY, SUBHANKAR, SUGUMARAN, AMARNATH, SATPATHY, ASHWINI, GADEKAR, ARVIND, MENON, SHALINI K., NEOGI, RENUKA, CHODANKAR, DEEPA, TRIVEDI, CHIRAG, KUMAR WANGNOO, SUBHASH, ZARGAR, ABDUL H., RAIS, NADEEM

“…Glycemic change from baseline to 3 years was examined in LANDMARC — a prospective observational study (CTRI/2017/05/008452) — that included participants with…”
Get full text

1333-P: Diabetes Complications in Metropolitan vs. Nonmetropolitan Cities of India—Three-Year Follow-up Results of LANDMARC Trial by KALRA, SANJAY, DAS, ASHOK K., JOSHI, SHASHANK R., MITHAL, AMBRISH, PRASANNA KUMAR, K.M., GOPALAKRISHNAN UNNIKRISHNAN, AMBIKA, THACKER, HEMANT, SETHI, BIPIN, CHOWDHURY, SUBHANKAR, SUGUMARAN, AMARNATH, SATPATHY, ASHWINI, GADEKAR, ARVIND, MENON, SHALINI K., NEOGI, RENUKA, CHODANKAR, DEEPA, TRIVEDI, CHIRAG, KUMAR WANGNOO, SUBHASH, ZARGAR, ABDUL H., RAIS, NADEEM

“…Macrovascular and microvascular complications were evaluated in participants from metropolitan versus non-metropolitan cities during the three years of…”
Get full text

1219-P: Therapy Trend in the Second Year of LANDMARC—Longitudinal Nationwide Study on Real-World Outcomes of Type 2 Diabetes in India by THACKER, HEMANT, DAS, ASHOK K., JOSHI, SHASHANK, MITHAL, AMBRISH, KALRA, SANJAY, UNNIKRISHNAN, AMBIKA GOPALAKRISHNAN, KUMAR, K.M. PRASANNA, SETHI, BIPIN, CHOWDHURY, SUBHANKAR, NAIR, ARJUN, MOHANASUNDARAM, SENTHILNATHAN, MENON, SHALINI K., SALVI, VAIBHAV, CHODANKAR, DEEPA, TRIVEDI, CHIRAG, WANGNOO, SUBHASH KUMAR, ZARGAR, ABDUL H., RAIS, NADEEM

“…Therapy patterns were examined across various subgroups during the second year of LANDMARC, a 3-year prospective observational study (CTRI/2017/05/008452) that…”
Get full text

1168-P: Complications in the Second Year of LANDMARC—Longitudinal Nationwide Study on Real-World Outcomes of Type 2 Diabetes in India by RAIS, NADEEM, DAS, ASHOK K., JOSHI, SHASHANK, MITHAL, AMBRISH, KALRA, SANJAY, UNNIKRISHNAN, AMBIKA GOPALAKRISHNAN, THACKER, HEMANT, SETHI, BIPIN, CHOWDHURY, SUBHANKAR, NAIR, ARJUN, MOHANASUNDARAM, SENTHILNATHAN, MENON, SHALINI K., SALVI, VAIBHAV, CHODANKAR, DEEPA, TRIVEDI, CHIRAG, WANGNOO, SUBHASH KUMAR, ZARGAR, ABDUL H., KUMAR, K.M. PRASANNA

“…Macrovascular and microvascular complications were evaluated during the first 2 years of LANDMARC, a 3-year prospective observational study…”
Get full text

1244-P: Glycemic Trend in the Second Year of LANDMARC—Longitudinal Nationwide Study on Real-World Outcomes of Type 2 Diabetes in India by JOSHI, SHASHANK, DAS, ASHOK K., KUMAR, K.M. PRASANNA, MITHAL, AMBRISH, KALRA, SANJAY, UNNIKRISHNAN, AMBIKA GOPALAKRISHNAN, THACKER, HEMANT, SETHI, BIPIN, CHOWDHURY, SUBHANKAR, NAIR, ARJUN, MOHANASUNDARAM, SENTHILNATHAN, MENON, SHALINI K., SALVI, VAIBHAV, CHODANKAR, DEEPA, TRIVEDI, CHIRAG, WANGNOO, SUBHASH KUMAR, ZARGAR, ABDUL H., RAIS, NADEEM

“…Glycemic change from baseline to 2-years was examined during the second year of LANDMARC, a 3-year prospective observational study (CTRI/2017/05/008452) ,…”
Get full text

1160-P: Diabetes Complications in Metropolitan vs. Nonmetropolitan Cities of India—Two-Year Results of LANDMARC by KALRA, SANJAY, DAS, ASHOK K., JOSHI, SHASHANK, MITHAL, AMBRISH, KUMAR, K.M. PRASANNA, UNNIKRISHNAN, AMBIKA GOPALAKRISHNAN, THACKER, HEMANT, SETHI, BIPIN, CHOWDHURY, SUBHANKAR, NAIR, ARJUN, MOHANASUNDARAM, SENTHILNATHAN, MENON, SHALINI K., SALVI, VAIBHAV, CHODANKAR, DEEPA, TRIVEDI, CHIRAG, WANGNOO, SUBHASH KUMAR, ZARGAR, ABDUL H., RAIS, NADEEM

“…There are few studies on type 2 diabetes complications from Indian metropolitan and non-metropolitan cities. Macrovascular and microvascular complications…”
Get full text

1248-P: Glycemic Trend in Metropolitan vs. Nonmetropolitan Cities of India-Two-Year Results of LANDMARC by UNNIKRISHNAN, AMBIKA GOPALAKRISHNAN, DAS, ASHOK K., JOSHI, SHASHANK, MITHAL, AMBRISH, KALRA, SANJAY, KUMAR, K.M. PRASANNA, THACKER, HEMANT, SETHI, BIPIN, CHOWDHURY, SUBHANKAR, NAIR, ARJUN, MOHANASUNDARAM, SENTHILNATHAN, MENON, SHALINI K., SALVI, VAIBHAV, CHODANKAR, DEEPA, TRIVEDI, CHIRAG, WANGNOO, SUBHASH KUMAR, ZARGAR, ABDUL H., RAIS, NADEEM

“…Glycemic trends of T2D from metropolitan and non-metropolitan cities of India have been less studied and hence, were evaluated during the second year of…”
Get full text

1087-P: Therapy Trends at One Year in the Longitudinal LANDMARC Study on Real-World Outcomes in Type 2 Diabetes Patients in India by THACKER, HEMANT, DAS, ASHOK K., JOSHI, SHASHANK, MITHAL, AMBRISH, KALRA, SANJAY, UNNIKRISHNAN, AMBIKA GOPALAKRISHNAN, KUMAR, K.M. PRASANNA, SETHI, BIPIN, CHOWDHURY, SUBHANKAR, GHOSH, ROMIK, KRISHNAN, SUKANYA, NAIR, ARJUN, MOHANASUNDARAM, SENTHILNATHAN, MENON, SHALINI K., SALVI, VAIBHAV, CHODANKAR, DEEPA, TRIVEDI, CHIRAG, WANGNOO, SUBHASH KUMAR, ZARGAR, ABDUL H., RAIS, NADEEM

“…Therapy patterns were examined across various subgroups during the first year of LANDMARC, a 3-year prospective observational study (CTRI/2017/05/008452) that…”
Get full text

1065-P: Glycemic Trend at One Year in a Longitudinal Nationwide Study on Real-World Outcomes of Type 2 Diabetes in India (LANDMARC) by JOSHI, SHASHANK, DAS, ASHOK K., KUMAR, K.M. PRASANNA, MITHAL, AMBRISH, KALRA, SANJAY, UNNIKRISHNAN, AMBIKA GOPALAKRISHNAN, THACKER, HEMANT, SETHI, BIPIN, CHOWDHURY, SUBHANKAR, GHOSH, ROMIK, KRISHNAN, SUKANYA, NAIR, ARJUN, MOHANASUNDARAM, SENTHILNATHAN, MENON, SHALINI K., SALVI, VAIBHAV, CHODANKAR, DEEPA, TRIVEDI, CHIRAG, WANGNOO, SUBHASH KUMAR, ZARGAR, ABDUL H., RAIS, NADEEM

Get full text

1095-P: Glycemic Trend in Metropolitan versus Non-metropolitan Cities of India: One-Year Results of LANDMARC by UNNIKRISHNAN, AMBIKA GOPALAKRISHNAN, DAS, ASHOK K., JOSHI, SHASHANK, MITHAL, AMBRISH, KALRA, SANJAY, KUMAR, K.M. PRASANNA, THACKER, HEMANT, SETHI, BIPIN, CHOWDHURY, SUBHANKAR, GHOSH, ROMIK, KRISHNAN, SUKANYA, NAIR, ARJUN, MOHANASUNDARAM, SENTHILNATHAN, MENON, SHALINI K., SALVI, VAIBHAV, CHODANKAR, DEEPA, TRIVEDI, CHIRAG, WANGNOO, SUBHASH KUMAR, ZARGAR, ABDUL H., RAIS, NADEEM

“…Data on glycemic status in patients with diabetes from metropolitan and non-metropolitan cities of India are unavailable. Hence, glycemic trend was evaluated…”
Get full text

1033-P: Complications at One Year in a Longitudinal Nationwide Study on Real-World Outcomes of Type 2 Diabetes in India (LANDMARC) by RAIS, NADEEM, DAS, ASHOK K., JOSHI, SHASHANK, MITHAL, AMBRISH, KALRA, SANJAY, UNNIKRISHNAN, AMBIKA GOPALAKRISHNAN, THACKER, HEMANT, SETHI, BIPIN, CHOWDHURY, SUBHANKAR, GHOSH, ROMIK, KRISHNAN, SUKANYA, NAIR, ARJUN, MOHANASUNDARAM, SENTHILNATHAN, MENON, SHALINI K., SALVI, VAIBHAV, CHODANKAR, DEEPA, TRIVEDI, CHIRAG, WANGNOO, SUBHASH KUMAR, ZARGAR, ABDUL H., KUMAR, K.M. PRASANNA

“…Complications (macrovascular and microvascular) during the first year of LANDMARC, a 3-year prospective observational study (CTRI/2017/05/008452) that included…”
Get full text